Targeted and pH-facilitated theranostic of orthotopic gastric cancer via phase-transformation doxorubicin-encapsulated nanoparticles enhanced by low-intensity focused ultrasound (LIFU) with reduced side effect

Zhangluxi Liu,1 Haitao Ran,2 Zhigang Wang,2 Shiji Zhou,1 Yaxu Wang1 1Department of Gastrointestinal Surgery, Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, People’s Republic of China; 2Institute of Ultrasound Imaging of Chongqing Medical University, Chongqing...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Liu Z, Ran H, Wang Z, Zhou S, Wang Y
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2019
Materias:	Low-intensity focused ultrasound Nanoparticles Phase transition Gastric cancer targeted anti-cancer therapy Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/450637dd65df44a6888441b8d0088080
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:450637dd65df44a6888441b8d0088080
record_format	dspace
spelling	oai:doaj.org-article:450637dd65df44a6888441b8d00880802021-12-02T11:05:13ZTargeted and pH-facilitated theranostic of orthotopic gastric cancer via phase-transformation doxorubicin-encapsulated nanoparticles enhanced by low-intensity focused ultrasound (LIFU) with reduced side effect1178-2013https://doaj.org/article/450637dd65df44a6888441b8d00880802019-09-01T00:00:00Zhttps://www.dovepress.com/targeted-and-ph-facilitated-theranostic-of-orthotopic-gastric-cancer-v-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Zhangluxi Liu,1 Haitao Ran,2 Zhigang Wang,2 Shiji Zhou,1 Yaxu Wang1 1Department of Gastrointestinal Surgery, Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, People’s Republic of China; 2Institute of Ultrasound Imaging of Chongqing Medical University, Chongqing 400010, People’s Republic of ChinaCorrespondence: Yaxu Wang; Shiji ZhouDepartment of Gastrointestinal Surgery, Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, People’s Republic of ChinaEmail wangyaxuhospital@163.com; zhoushiji@hospital.cqmu.edu.cnPurpose: Focused ultrasound-mediated chemotherapy, as a non-invasive therapeutic modality, has been extensively explored in combating deep tumors for predominant penetration performance. However, the generally used high-intensity focused ultrasound (HIFU) inevitably jeopardizes normal tissue around the lesion for hyperthermal energy. To overcome this crucial issue, low-intensity focused ultrasound (LIFU) was introduced to fulfill precisely controlled imaging and therapy in lieu of HIFU. The objective of this study was to develop a facile and versatile nanoplatform (DPP-R) in response to LIFU and provide targeted drug delivery concurrently.Methods: Multifunctional DPP-R was fabricated by double emulsion method and carbodiimide method. Physicochemical properties of DPP-R were detected respectively and the bio-compatibility and bio-safety were evaluated by CCK-8 assay, blood analysis, and histologic section. The targeted ability, imaging function, and anti-tumor effect were demonstrated in vitro and vivo.Results: The synthetic DPP-R showed an average particle size at 367 nm, stable physical-chemical properties in different media, and high bio-compatibility and bio-safety. DPP-R was demonstrated to accumulate at the tumor site by active receptor/ligand reaction and passive EPR effect with intravenous administration. Stimulated by LIFU at the tumor site, phase-transformable PFH was vaporized in the core of the integration offering contrast-enhanced ultrasound imaging. The stimuli led to encapsulated DOX’s initial burst release and subsequent sustained release for anti-tumor therapy which was verified to be more effective and have less adverse effects than free DOX.Conclusion: DPP-R combined with LIFU provides a novel theranostic modality for GC treatment with potent therapeutic effect, including prominent performance of targeting, ultrasound imaging, and accurate drug release.Keywords: low-intensity focused ultrasound, nanoparticles, phase-transition, gastric cancer, targeted anti-cancer therapyLiu ZRan HWang ZZhou SWang YDove Medical PressarticleLow-intensity focused ultrasoundNanoparticlesPhase transitionGastric cancertargeted anti-cancer therapyMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 14, Pp 7627-7642 (2019)
institution	DOAJ
collection	DOAJ
language	EN
topic	Low-intensity focused ultrasound Nanoparticles Phase transition Gastric cancer targeted anti-cancer therapy Medicine (General) R5-920
spellingShingle	Low-intensity focused ultrasound Nanoparticles Phase transition Gastric cancer targeted anti-cancer therapy Medicine (General) R5-920 Liu Z Ran H Wang Z Zhou S Wang Y Targeted and pH-facilitated theranostic of orthotopic gastric cancer via phase-transformation doxorubicin-encapsulated nanoparticles enhanced by low-intensity focused ultrasound (LIFU) with reduced side effect
description	Zhangluxi Liu,1 Haitao Ran,2 Zhigang Wang,2 Shiji Zhou,1 Yaxu Wang1 1Department of Gastrointestinal Surgery, Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, People’s Republic of China; 2Institute of Ultrasound Imaging of Chongqing Medical University, Chongqing 400010, People’s Republic of ChinaCorrespondence: Yaxu Wang; Shiji ZhouDepartment of Gastrointestinal Surgery, Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, People’s Republic of ChinaEmail wangyaxuhospital@163.com; zhoushiji@hospital.cqmu.edu.cnPurpose: Focused ultrasound-mediated chemotherapy, as a non-invasive therapeutic modality, has been extensively explored in combating deep tumors for predominant penetration performance. However, the generally used high-intensity focused ultrasound (HIFU) inevitably jeopardizes normal tissue around the lesion for hyperthermal energy. To overcome this crucial issue, low-intensity focused ultrasound (LIFU) was introduced to fulfill precisely controlled imaging and therapy in lieu of HIFU. The objective of this study was to develop a facile and versatile nanoplatform (DPP-R) in response to LIFU and provide targeted drug delivery concurrently.Methods: Multifunctional DPP-R was fabricated by double emulsion method and carbodiimide method. Physicochemical properties of DPP-R were detected respectively and the bio-compatibility and bio-safety were evaluated by CCK-8 assay, blood analysis, and histologic section. The targeted ability, imaging function, and anti-tumor effect were demonstrated in vitro and vivo.Results: The synthetic DPP-R showed an average particle size at 367 nm, stable physical-chemical properties in different media, and high bio-compatibility and bio-safety. DPP-R was demonstrated to accumulate at the tumor site by active receptor/ligand reaction and passive EPR effect with intravenous administration. Stimulated by LIFU at the tumor site, phase-transformable PFH was vaporized in the core of the integration offering contrast-enhanced ultrasound imaging. The stimuli led to encapsulated DOX’s initial burst release and subsequent sustained release for anti-tumor therapy which was verified to be more effective and have less adverse effects than free DOX.Conclusion: DPP-R combined with LIFU provides a novel theranostic modality for GC treatment with potent therapeutic effect, including prominent performance of targeting, ultrasound imaging, and accurate drug release.Keywords: low-intensity focused ultrasound, nanoparticles, phase-transition, gastric cancer, targeted anti-cancer therapy
format	article
author	Liu Z Ran H Wang Z Zhou S Wang Y
author_facet	Liu Z Ran H Wang Z Zhou S Wang Y
author_sort	Liu Z
title	Targeted and pH-facilitated theranostic of orthotopic gastric cancer via phase-transformation doxorubicin-encapsulated nanoparticles enhanced by low-intensity focused ultrasound (LIFU) with reduced side effect
title_short	Targeted and pH-facilitated theranostic of orthotopic gastric cancer via phase-transformation doxorubicin-encapsulated nanoparticles enhanced by low-intensity focused ultrasound (LIFU) with reduced side effect
title_full	Targeted and pH-facilitated theranostic of orthotopic gastric cancer via phase-transformation doxorubicin-encapsulated nanoparticles enhanced by low-intensity focused ultrasound (LIFU) with reduced side effect
title_fullStr	Targeted and pH-facilitated theranostic of orthotopic gastric cancer via phase-transformation doxorubicin-encapsulated nanoparticles enhanced by low-intensity focused ultrasound (LIFU) with reduced side effect
title_full_unstemmed	Targeted and pH-facilitated theranostic of orthotopic gastric cancer via phase-transformation doxorubicin-encapsulated nanoparticles enhanced by low-intensity focused ultrasound (LIFU) with reduced side effect
title_sort	targeted and ph-facilitated theranostic of orthotopic gastric cancer via phase-transformation doxorubicin-encapsulated nanoparticles enhanced by low-intensity focused ultrasound (lifu) with reduced side effect
publisher	Dove Medical Press
publishDate	2019
url	https://doaj.org/article/450637dd65df44a6888441b8d0088080
work_keys_str_mv	AT liuz targetedandphfacilitatedtheranosticoforthotopicgastriccancerviaphasetransformationdoxorubicinencapsulatednanoparticlesenhancedbylowintensityfocusedultrasoundlifuwithreducedsideeffect AT ranh targetedandphfacilitatedtheranosticoforthotopicgastriccancerviaphasetransformationdoxorubicinencapsulatednanoparticlesenhancedbylowintensityfocusedultrasoundlifuwithreducedsideeffect AT wangz targetedandphfacilitatedtheranosticoforthotopicgastriccancerviaphasetransformationdoxorubicinencapsulatednanoparticlesenhancedbylowintensityfocusedultrasoundlifuwithreducedsideeffect AT zhous targetedandphfacilitatedtheranosticoforthotopicgastriccancerviaphasetransformationdoxorubicinencapsulatednanoparticlesenhancedbylowintensityfocusedultrasoundlifuwithreducedsideeffect AT wangy targetedandphfacilitatedtheranosticoforthotopicgastriccancerviaphasetransformationdoxorubicinencapsulatednanoparticlesenhancedbylowintensityfocusedultrasoundlifuwithreducedsideeffect
_version_	1718396285262757888

Targeted and pH-facilitated theranostic of orthotopic gastric cancer via phase-transformation doxorubicin-encapsulated nanoparticles enhanced by low-intensity focused ultrasound (LIFU) with reduced side effect

Ejemplares similares